← brief for 2026-08-13 · Slowing decline
Jardiance
Key takeaways
This trial showed dapagliflozin reduces risk of kidney failure and cardiovascular death. It was a large trial with 3,200 patients over 3 years.
Who did this work
Aphena Pharma Solutions - Tennessee, LLC
Source
Paper · openFDA, renal drug labels · 2026-06-17
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=334f1b3d-5670-6685-e063-6294a90a7e47